ACC/AHA/NHLBI clinical advisory on the use and safety of statins
Top Cited Papers
- 25 July 2002
- journal article
- guideline
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 40 (3), 567-572
- https://doi.org/10.1016/s0735-1097(02)02030-2
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Cerivastatin and Reports of Fatal RhabdomyolysisNew England Journal of Medicine, 2002
- Effect of combined fluvastatin-fenofibrate therapy compared with fenofibrate monotherapy in severe primary hypercholesterolemiaThe American Journal of Cardiology, 2000
- Concomitant use of cytochrome P450 3A4 inhibitors and simvastatinThe American Journal of Cardiology, 1999
- Long-Term safety of pravastatin-gemfibrozil therapy in mixed hyperlipidemiaClinical Cardiology, 1999
- Use of HMG-CoA Reductase Inhibitors after Kidney and Heart TransplantationBioDrugs, 1997
- HMG CoA Reductase Inhibitor-Induced Myotoxicity: Pravastatin and Lovastatin Inhibit the Geranylgeranylation of Low-Molecular-Weight Proteins in Neonatal Rat Muscle Cell CultureToxicology and Applied Pharmacology, 1997
- Long-term Treatment With Pravastatin Alone and in Combination With Gemfibrozil in Familial Type IIB Hyperlipoproteinemia or Combined HyperlipidemiaJournal of Cardiovascular Pharmacology and Therapeutics, 1997
- The effect of Simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscleThe American Journal of Cardiology, 1996
- Benefits and Risks of HMG-CoA Reductase Inhibitors in the Prevention of Coronary Heart Disease A ReappraisalDrug Safety, 1996
- Safety of combined pravastatin-gemfibrozil therapyThe American Journal of Cardiology, 1994